Skip to content

    Arcus Biosciences (RCUS) stock price & financials

    View RCUS earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+176.6% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $48.00M
    $26.00M
    $28.00M
    $160.00M
    $26.00M
    -45.8%
    $33.00M
    +26.9%
    $17.00M
    -39.3%
    $41.00M
    -74.4%
    Weakening
    Operating Profit
    -$105.00M
    -$103.00M
    -$122.00M
    -$8.00M
    -$142.00M
    -35.2%
    -$114.00M
    -10.7%
    -$134.00M
    -9.8%
    -$96.00M
    -1100.0%
    Weakening
    Net Profit
    -$92.00M
    -$94.00M
    -$112.00M
    $0
    -$135.00M
    -46.7%
    -$106.00M
    -12.8%
    -$128.00M
    -14.3%
    -$91.00M
    Weakening
    EPS
    $-1.00
    $-1.14
    $0.00
    $-1.27
    -27.0%
    $-1.02
    +10.5%
    $-0.72
    Strengthening
    Other Income
    $13.00M
    $10.00M
    $10.00M
    $8.00M
    $7.00M
    -46.2%
    $8.00M
    -20.0%
    $6.00M
    -40.0%
    $5.00M
    -37.5%
    Weakening
    Interest
    $1.00M
    $2.00M
    $1.00M
    $2.00M
    $3.00M
    +200.0%
    $2.00M
    +0.0%
    $3.00M
    +200.0%
    $3.00M
    +50.0%
    Strengthening
    Depreciation
    Profit before Tax
    -$92.00M
    -$93.00M
    -$112.00M
    $0
    -$135.00M
    -46.7%
    -$106.00M
    -14.0%
    -$128.00M
    -14.3%
    -$91.00M
    Weakening
    MarginsOPM
    -218.8%
    -396.1%
    -435.7%
    -5.0%
    -546.1%
    -149.7%
    -345.4%
    +12.8%
    -788.2%
    -80.9%
    -234.2%
    -4583.0%
    Weakening
    Tax
    0.0%
    -1.1%
    0.0%
    0.0%
    0.0%
    +100.0%
    0.0%
    0.0%
    Strengthening
    ReturnsROIC
    -19.8%
    -20.2%
    -24.1%
    0.0%
    -29.0%
    -46.7%
    -22.8%
    -12.8%
    -27.5%
    -14.3%
    -19.6%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$71.06M$57.94M$173.41M$148.00M$206.00M$127.00M$150.00M$222.00M$150.00M
    Short-Term Investments
    Total Current Assets$258.95M$192.71M$735.82M$1.26B$1.07B$831.00M$1.02B$1.01B$756.00M
    Net PP&E$11.11M$9.33M$23.59M$137.00M$135.00M$143.00M$112.00M$98.00M$36.00M
    Goodwill
    Intangibles
    Total Assets$274.93M$203.11M$772.29M$1.59B$1.34B$1.09B$1.15B$1.14B$924.00M
    LiabilitiesTotal Current Liabilities$16.93M$22.71M$121.67M$166.00M$193.00M$184.00M$226.00M$231.00M$198.00M
    Short-Term Debt
    Long-Term Debt$0$48.00M$99.00M$101.00M
    Long-Term Leases$15.24M$117.00M$117.00M$110.00M$99.00M$86.00M
    Total Liabilities$39.98M$39.27M$269.99M$750.45M$688.00M$633.00M$665.00M$508.00M$460.00M
    EquityCommon Stock & APIC$4.0K$4.0K$6.0K$1.12B$1.21B$1.31B$1.62B$2.12B$2.17B
    Retained Earnings-$122.83M-$205.33M-$328.18M-$275.00M-$542.00M-$849.00M-$1.13B-$1.49B-$1.70B
    Total Equity$234.94M$164.00M$502.00M$842.00M$657.00M$462.00M$485.00M$631.00M$464.00M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$43.00M-$73.46M$111.00M-$256.00M$438.00M-$306.00M-$170.00M-$482.00M-$474.00M
    Cash from Investing-$113.44M$59.21M-$434.00M-$4.00M-$413.00M$194.00M-$84.00M$66.00M$63.00M
    Cash from Financing$129.07M$1.12M$439.00M$237.00M$33.00M$33.00M$277.00M$488.00M$313.00M
    SummaryCapital Expenditure-$3.74M-$1.93M-$3.00M-$26.00M-$6.00M-$24.00M-$6.00M-$2.00M-$1.00M
    Free Cash Flow-$46.74M-$75.39M$108.00M-$282.00M$432.00M-$330.00M-$176.00M-$484.00M-$475.00M
    FCF Margin-559.5%-502.6%138.5%-73.6%385.7%-282.1%-68.2%-196.0%-406.0%

    Ratios